Overview 

Blenoxane was a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating Hodgkin lymphoma and non-Hodgkin lymphoma. Blenoxane was often combined with other drugs such as doxorubicin, vinblastine sulfate, and corticosteroids in specific chemotherapy regimens. Blenoxane was also known by its drug name, bleomycin.

Blenoxane was an anticancer drug used in chemotherapy. Blenoxane was a member of a drug class called antitumor antibiotics. Blenoxane was believed to work by interfering with DNA synthesis and blocking cell division in several ways. 

How was it taken? 

Blenoxane was usually administered as an intravenous infusion during chemotherapy treatment.

Side effects 

The FDA-approved label for Blenoxane listed common side effects including fever, chills, nausea, vomiting, weight loss, hair loss, mouth sores, changes to the nails, and skin reactions such as color changes, peeling, stretch marks, and sores.

Rare but serious side effects listed for Blenoxane included allergic reactions, lung conditions such as pneumonitis or pulmonary fibrosis, and changes to the cardiovascular system that raise the risk for stroke or heart attack. 

For more details about this treatment, visit:

Blenoxane — Drugs.com